Fosun Pharma repurchases 1.245m shares

Shanghai Fosun Pharmaceutical Group Co., Ltd. (the "Company"), a publicly traded entity on the Hong Kong Stock Exchange (stock code: SSE:600196), announced that it has repurchased 1,245,300 shares on June 18, 2025. The shares, classified as A shares, were repurchased on the Shanghai Stock Exchange. The repurchase price ranged between RMB 24.77 and RMB 24.96 per share, resulting in a total expenditure of RMB 30,995,929. Following the repurchase, the company's total issued shares stand at 2,118,488,825. The repurchased shares will be held as treasury shares. This buyback aligns with the company's existing repurchase mandate.